In this guide
What is Calcium D-Glucarate?
Calcium D-glucarate is the calcium salt of D-glucaric acid. Its metabolites can inhibit beta-glucuronidase in experimental systems, potentially affecting deconjugation of glucuronides. That biochemical mechanism does not show that an oral retail product improves a clinical outcome in humans. [1], [4]
Typical Calcium D-Glucarate Protocols
| Source and question | Preparation | Amount each administration | Daily total | Frequency and duration | Main interpretation |
|---|---|---|---|---|---|
| Evidence boundary · no controlled human efficacy trial identified | Commercial calcium D-glucarate | No verified amount | No verified daily total | No controlled human schedule established | No source-specific human efficacy protocol can be reported |
| Walaszek 1997 · rat radiotracer study | Potassium hydrogen D-[14C]glucarate in rats | Animal exposure; not transferable | Animal exposure; not a human total | Experimental animal schedule | Mapped uptake, metabolism and excretion; cannot define a human supplement regimen |
| Saluk-Juszczak 2010 · in-vitro platelet study | Calcium D-glucarate added to isolated human blood platelets | Laboratory concentration, not an oral administration | No oral daily total | Ex-vivo laboratory exposure | Oxidative and activation markers changed in a platelet model; no participant received a supplement |
- Exact product
- Record species, form, lot and co-ingredients.
- Each administration
- Keep amount, timing and context.
- Real endpoint
- Separate biomarker, symptom and clinical outcome.
What is it commonly used for?
It is marketed for detoxification, estrogen metabolism, cholesterol and cancer prevention. The frequently cited 2002 review is an unsigned narrative in Alternative Medicine Review, not a controlled human trial. Older pharmacology and cancer-prevention work is largely animal or laboratory research. A platelet study used an in-vitro human blood model, and a 2023 systems-biology paper was computational. No source here provides a verified controlled human efficacy protocol. [1], [2], [4]
One result answers one question
How do forms and labels differ?
Calcium D-glucarate, glucaric acid, glucarolactone and food sources of glucarate are related but not interchangeable exposures. Salt mass also includes calcium. Record the exact chemical form, elemental calcium if declared, product testing, co-ingredients and medications rather than translating an animal concentration into a human amount. [4], [5]
How should the product be stored?
Follow the finished product’s label, keep it dry in its original container and away from children. Discard an expired, heat-damaged, broken-seal or untraceable product.
What does human research show?
| Question | Best direct evidence | Finding | Boundary |
|---|---|---|---|
| Efficacy | Evidence boundary · no controlled human efficacy trial identified | No source-specific human efficacy protocol can be reported | Specific product and population |
| Replication | Limited evidence | No universal effect established | Variable formulations |
| Universal dose? | None | Not established | Rows cannot be combined |
Keep the finished product reviewable
What are the risks and interactions?
Human safety and interaction data are inadequate for long-term supplemental exposure. Altering deconjugation is hypothesized to affect elimination of endogenous compounds and medicines, but the clinical size and direction are unknown. Pregnancy, breastfeeding, cancer treatment, hormone-sensitive disease, kidney disease, hypercalcemia, calcium-sensitive medicines or narrow-therapeutic-index drugs require clinician or pharmacist review. [2], [3], [5], [6]
Seek prompt care for severe weakness, confusion, repeated vomiting, dehydration, abnormal heart rhythm, severe allergy or a suspected medicine interaction.
What is the legal and regulatory status?
Calcium D-glucarate is marketed as a dietary supplement in the United States; FDA does not approve supplements for safety and effectiveness before sale. In Canada, verify the exact product, NPN and authorized claims. Retail status does not establish detoxification or disease-prevention efficacy. [6]
When should use stop?
Stop for any allergic reaction, persistent symptom worsening, unexpected laboratory result or doubt about product identity.
What should be monitored?
Without a validated human efficacy protocol, do not use a beta-glucuronidase test or nonspecific detox symptom as proof. Record product identity, chemical form, amount, elemental calcium, duration, medicines, adverse effects and the actual clinical endpoint. Reassess the rationale when the endpoint cannot be defined or measured.
What can community experience add?
Reports can reveal capsule burden, gastrointestinal symptoms and marketing language. They cannot establish glucuronide clearance, lower cancer risk or safer hormone metabolism. No systematic current community sample was assembled, so no consensus detox cycle is reported.
How do related options compare?
| Option | Main distinction |
|---|---|
| Calcium D-glucarate | Supplement salt with unproven human efficacy |
| Glucarolactone | Experimental beta-glucuronidase inhibitor metabolite |
| Fruit and vegetables | Food matrix; not a capsule-equivalent exposure |
Common questions
Does it detox the liver?
No controlled human clinical outcome supports that broad claim.
Does beta-glucuronidase inhibition prove benefit?
No. A biochemical mechanism can exist without a meaningful or safe clinical effect.
Does it balance estrogen?
That marketing claim lacks verified controlled human efficacy evidence.
Can an animal dose be converted?
No. Species, formulation, metabolism and endpoint prevent a responsible consumer conversion.
Is the 2002 article a trial?
No. It is an unsigned narrative review, not a randomized human study.
What should be tracked?
Chemical form, amount, elemental calcium, medicines, duration and a real clinical endpoint.
Glossary
Terms for reading the evidence.
- Endpoint
- A defined result measured in a study.
- Anaphylaxis
- A potentially life-threatening systemic allergic reaction.
- Biomarker
- A biological measure that does not guarantee clinical benefit.
- Standardization
- A measured specification for a product component.
- Cross-reactivity
- Immune recognition of related proteins from different sources.
How this guide was researched
NCBI identities, publication notices, indexed abstracts and available open methods were checked. Null outcomes, mixed products, surrogate endpoints and missing details remain visible.
Research record · checked October 9, 2026
Identity: NCBI EFetch verified the indexed records by title, first author, journal, pages, DOI and descendant notices. No linked correction, retraction or expression of concern appeared.
Evidence class: the 2002 article is an unsigned narrative review; Walaszek is animal pharmacology; Saluk-Juszczak is an isolated-platelet model; Ayyadurai is computational.
Boundary: no animal, in-vitro or computational exposure was converted into a human amount. No systematic current community sample was assembled.
Explore the sources
Primary human evidence and official context.
Showing 6 sources
- 01
Calcium-D-glucarate. ↗
Unsigned narrative review
Summarizes mechanisms and proposed uses but reports no controlled human efficacy trial and lists no authors in the indexed record.
- 02
Metabolism, uptake, and excretion of a D-glucaric acid salt and its potential use in cancer prevention. ↗
Animal pharmacology study
Radiolabeled potassium glucarate was administered to rats; metabolism and tissue uptake do not define a human oral regimen.
- 03
A comparative study of antioxidative activity of calcium-D-glucarate, sodium-D-gluconate and D-glucono-1,4-lactone in a human blood platelet model. ↗
In-vitro human platelet study
Isolated platelets were exposed in the laboratory; no participant ingested calcium D-glucarate.
- 04
Mechanistic Understanding of D-Glucaric Acid to Support Liver Detoxification Essential to Muscle Health Using a Computational Systems Biology Approach. ↗
Computational systems-biology study
Computational pathway analysis generated mechanistic hypotheses rather than human clinical outcomes.
- 05
Calcium Glucarate ↗
Institutional evidence overview
Notes that claimed detoxification and cancer uses are based mainly on animal studies and that clinical evidence is lacking.
- 06
FDA 101: Dietary Supplements ↗
Official supplement overview
FDA does not approve dietary supplements for safety and effectiveness before sale.
No matching sources
Try a different term or show the full list.
Editorial note
This guide separates composition, biomarker, symptom and clinical outcome. It does not turn a narrow signal into a general promise.